Cargando…

Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?

OBJECTIVES: To compare the 7.5–9.5F ureteroscope (URS) with the 4.5–6.5F URS (Ultra-Thin) in terms of success and complication rates in adult patients with ureteric and renal pelvic stones. PATIENTS AND METHODS: In all, 41 patients treated with 7.5–9.5F semi-rigid URS (Group 1) and 33 patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzun, Hakkı, Akça, Nezih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277274/
https://www.ncbi.nlm.nih.gov/pubmed/30534443
http://dx.doi.org/10.1016/j.aju.2018.04.006
_version_ 1783378124974587904
author Uzun, Hakkı
Akça, Nezih
author_facet Uzun, Hakkı
Akça, Nezih
author_sort Uzun, Hakkı
collection PubMed
description OBJECTIVES: To compare the 7.5–9.5F ureteroscope (URS) with the 4.5–6.5F URS (Ultra-Thin) in terms of success and complication rates in adult patients with ureteric and renal pelvic stones. PATIENTS AND METHODS: In all, 41 patients treated with 7.5–9.5F semi-rigid URS (Group 1) and 33 patients treated with the Ultra-Thin (Group 2) were prospectively included in the study. All patients underwent holmium laser ureteroscopic lithotripsy. In each group, when the selected ureteroscopic intervention failed to reach or disintegrate the stone, the URS was replaced with the other one. Outcome criteria were: success and complication rates, stone size and stone surface area, operative time, laser time, usage of guidewire, and postoperative JJ-catheter placement. RESULTS: The ureteroscopic lithotripsy in 36 of 41 (87.8%) and 24 of 33 (72.7%) patients was completed without a need to replace the URS with the other one in groups 1 and 2, respectively (P = 0.67). After replacement of the 7.5–9.5F URS with the Ultra-Thin for patients who failed in Group 1, the overall stone-free rate (SFR) improved to 97.5% (P = 0.014). In Group 2, after replacement of the Ultra-Thin with the 7.5–9.5F URS for the failed patients, the overall SFR improved to 96.9% (P = 0.02). There was no significant difference between the groups for complications. Postoperative JJ stenting was significantly less in Group 2 (21.2%) in comparison to Group 1 (46.3%) (P = 0.02). CONCLUSIONS: The Ultra-Thin has a similar success rate as the 7.5–9.5F URS in the treatment of ureteric stones and is a feasible option in patients in whom a conventional URS cannot be advanced through any segment of the ureter.
format Online
Article
Text
id pubmed-6277274
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62772742018-12-10 Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones? Uzun, Hakkı Akça, Nezih Arab J Urol Stone/Endourology OBJECTIVES: To compare the 7.5–9.5F ureteroscope (URS) with the 4.5–6.5F URS (Ultra-Thin) in terms of success and complication rates in adult patients with ureteric and renal pelvic stones. PATIENTS AND METHODS: In all, 41 patients treated with 7.5–9.5F semi-rigid URS (Group 1) and 33 patients treated with the Ultra-Thin (Group 2) were prospectively included in the study. All patients underwent holmium laser ureteroscopic lithotripsy. In each group, when the selected ureteroscopic intervention failed to reach or disintegrate the stone, the URS was replaced with the other one. Outcome criteria were: success and complication rates, stone size and stone surface area, operative time, laser time, usage of guidewire, and postoperative JJ-catheter placement. RESULTS: The ureteroscopic lithotripsy in 36 of 41 (87.8%) and 24 of 33 (72.7%) patients was completed without a need to replace the URS with the other one in groups 1 and 2, respectively (P = 0.67). After replacement of the 7.5–9.5F URS with the Ultra-Thin for patients who failed in Group 1, the overall stone-free rate (SFR) improved to 97.5% (P = 0.014). In Group 2, after replacement of the Ultra-Thin with the 7.5–9.5F URS for the failed patients, the overall SFR improved to 96.9% (P = 0.02). There was no significant difference between the groups for complications. Postoperative JJ stenting was significantly less in Group 2 (21.2%) in comparison to Group 1 (46.3%) (P = 0.02). CONCLUSIONS: The Ultra-Thin has a similar success rate as the 7.5–9.5F URS in the treatment of ureteric stones and is a feasible option in patients in whom a conventional URS cannot be advanced through any segment of the ureter. Elsevier 2018-06-21 /pmc/articles/PMC6277274/ /pubmed/30534443 http://dx.doi.org/10.1016/j.aju.2018.04.006 Text en © 2018 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Stone/Endourology
Uzun, Hakkı
Akça, Nezih
Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title_full Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title_fullStr Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title_full_unstemmed Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title_short Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones?
title_sort is the 4.5-f ureteroscope (ultra-thin) an alternative in the management of ureteric and renal pelvic stones?
topic Stone/Endourology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277274/
https://www.ncbi.nlm.nih.gov/pubmed/30534443
http://dx.doi.org/10.1016/j.aju.2018.04.006
work_keys_str_mv AT uzunhakkı isthe45fureteroscopeultrathinanalternativeinthemanagementofuretericandrenalpelvicstones
AT akcanezih isthe45fureteroscopeultrathinanalternativeinthemanagementofuretericandrenalpelvicstones